Browsing by Author "Waldie, S"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Apolipoprotein E binding drives structural and compositional rearrangement of mRNA-containing lipid nanoparticles
    (American Chemical Society (ACS), 2021-03-23) Sebastiani, F; Yanez Arteta, M; Lerche, M; Porcar, L; Lang, C; Bragg, RA; Elmore, CS; Krishnamurthy, VR; Russell, RA; Darwish, TA; Pichler, H; Waldie, S; Moulin, M; Haertlein, M; Forsyth, VT; Lindfors, L; Cárdenas, M
    Emerging therapeutic treatments based on the production of proteins by delivering mRNA have become increasingly important in recent times. While lipid nanoparticles (LNPs) are approved vehicles for small interfering RNA delivery, there are still challenges to use this formulation for mRNA delivery. LNPs are typically a mixture of a cationic lipid, distearoylphosphatidylcholine (DSPC), cholesterol, and a PEG-lipid. The structural characterization of mRNA-containing LNPs (mRNA-LNPs) is crucial for a full understanding of the way in which they function, but this information alone is not enough to predict their fate upon entering the bloodstream. The biodistribution and cellular uptake of LNPs are affected by their surface composition as well as by the extracellular proteins present at the site of LNP administration, e.g., apolipoproteinE (ApoE). ApoE, being responsible for fat transport in the body, plays a key role in the LNP's plasma circulation time. In this work, we use small-angle neutron scattering, together with selective lipid, cholesterol, and solvent deuteration, to elucidate the structure of the LNP and the distribution of the lipid components in the absence and the presence of ApoE. While DSPC and cholesterol are found to be enriched at the surface of the LNPs in buffer, binding of ApoE induces a redistribution of the lipids at the shell and the core, which also impacts the LNP internal structure, causing release of mRNA. The rearrangement of LNP components upon ApoE incubation is discussed in terms of potential relevance to LNP endosomal escape. © 2021 American Chemical Society. Open Access. This publication is licensed under CC-BY 4.0.
  • Thumbnail Image
    Item
    High-density lipoprotein function is modulated by the SARS-CoV-2 spike protein in a lipid-type dependent manner
    (Elsevier B. V., 2023-09) Correa, YB; Del Giuduce, R; Waldie, S; Thépaut, M; Gerelli, Y; Moulin, M; Delauney, C; Fieschi, F; Haertlein, M; Le Brun, AP; Forsyth, VT; Moir, M; Russell, RA; Darwish, TA; Brinck, J; Wodaje, T; Jansen, M; Martín, C; Roosen-Runge, F; Cárdenas, M; Micciulla, S; Pichler, H
    There is a close relationship between the SARS-CoV-2 virus and lipoproteins, in particular high-density lipoprotein (HDL). The severity of the coronavirus disease 2019 (COVID-19) is inversely correlated with HDL plasma levels. It is known that the SARS-CoV-2 spike (S) protein binds the HDL particle, probably depleting it of lipids and altering HDL function. Based on neutron reflectometry (NR) and the ability of HDL to efflux cholesterol from macrophages, we confirm these observations and further identify the preference of the S protein for specific lipids and the consequent effects on HDL function on lipid exchange ability. Moreover, the effect of the S protein on HDL function differs depending on the individuals lipid serum profile. Contrasting trends were observed for individuals presenting low triglycerides/high cholesterol serum levels (LTHC) compared to high triglycerides/high cholesterol (HTHC) or low triglycerides/low cholesterol serum levels (LTLC). Collectively, these results suggest that the S protein interacts with the HDL particle and, depending on the lipid profile of the infected individual, it impairs its function during COVID-19 infection, causing an imbalance in lipid metabolism. © Crown Copyright 2023. Published by Elsevier Inc. Open Access - CC BY licence 4.0.